RastogiAWaliaRSaikiaUNBhansaliA. Macroorchidism: Consequence of untreated congenital adrenal hyperplasia. Indian Pediatr2012;49:577–578.
2.
ChipkevitchENishimuraRTTuDGGalea-RojasM. Clinical measurement of testicular volume in adolescents: Comparison of the reliability of 5 methods. J Urol1996;156:2050–2053.
3.
BritoVNLatronicoACArnholdIJMendoncaBB. Update on the etiology, diagnosis and therapeutic management of sexual precocity. Arq Bras Endocrinol Metabol2008;52:18–31.
BarbieriRLSaltzmanDPhillippeM. Elevated beta-human chorionic gonadotropin and testosterone in cord serum of male infants of diabetic mothers. J Clin Endocrinol Metab1985;61:976–979.
6.
DoshiNSurtiUSzulmanAE. Morphologic anomalies in triploid liveborn fetuses. Hum Pathol1983;14:716–723.
Mostoufi-ZadehMWeissLMDriscollSG. Nonimmune hydrops fetalis: A challenge in perinatal pathology. Hum Pathol1985;16:785–789.
9.
ZondekLHZondekT. Leydig cells of the foetus and newborn in various complications of pregnancy. Acta Obstet Gynecol Scand1967;46:392–413.
10.
CohenMMJr. Beckwith-Wiedemann syndrome: Historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol2005;8:287–304.
11.
BeckwithJB. Extreme cytomegaly of the adrenal fetal cortex, omphalocele, hyperplasia of kidneys and pancreas, and Leydig-cell hyperplasia: Another syndrome?Western Society for Pediatric Research; 11 November, 1963; Los Angeles, CA1963.
12.
WiedemannHR. [Familial malformation complex with umbilical hernia and macroglossia—a “new syndrome”?]. J Genet Hum1964;13:223–232.
13.
ElliottMMaherER. Beckwith-Wiedemann syndrome. J Med Genet1994;31:560–564.
14.
LimDBowdinSCTeeL. Clinical and molecular genetic features of Beckwith-Wiedemann syndrome associated with assisted reproductive technologies. Hum Reprod2009;24:741–747.
15.
UyarASeliE. The impact of assisted reproductive technologies on genomic imprinting and imprinting disorders. Curr Opin Obstet Gynecol2014;26:210–221.
16.
GreerKJKirkpatrickSJWeksbergRPauliRM. Beckwith-Wiedemann syndrome in adults: Observations from one family and recommendations for care. Am J Med Genet A2008;146A:1707–1712.
17.
LaronZZilkaE. Compensatory hypertrophy of testicle in unilateral cryptorchidism. J Clin Endocrinol Metab1969;29:1409–1413.
18.
KoffSA. Does compensatory testicular enlargement predict monorchism?J Urol1991;146(Pt 2):632–633.
19.
KuJHSonHKwakCLeeSELeeNKParkYH. Impact of varicocele on testicular volume in young men: Significance of compensatory hypertrophy of contralateral testis. J Urol2002;168(4 Pt 1):1541–1544.
20.
LaronZDickermanZPrager-LewinRKeretRHalabeE. Plasma LH and FSH response to LRH in boys with compensatory testicular hypertrophy. J Clin Endocrinol Metab1975;40:977–981.
21.
LaronZDickermanZRittermanIKaufmanH. Follow-up of boys with unilateral compensatory testicular hypertrophy. Fertil Steril1980;33:297–301.
HuffDSSnyderHMIIIHadziselimovicFBlythBDuckettJW. An absent testis is associated with contralateral testicular hypertrophy. J Urol1992;148(2 Pt 2):627–628.
24.
GaudinoRCavarzerePCamilotMTeofoliFZampieriNTatoL. Prepubertal serum inhibin B in cryptorchid infants and in monorchid boys with compensatory testicular hypertrophy. Fertil Steril2008;90:2217–2221.
25.
BreenDHBraunsteinGDNeufeldNKudishH. Benign macroorchidism in a pubescent boy. J Urol1981;125:589–591.
LeePAMarshallFFGrecoJMJeffsRD. Unilateral testicular hypertrophy: An apparently benign occurrence without cryptorchidism. J Urol1982;127:329–331.
29.
GarciaM Alvarez-AcevedoRodriguezMA MolinaCasadoI Gonzalezde SerranoM Nistal MartinBouthelierR Gracia. [Macroorchidism: A case report]. An Pediatr (Barc)2006;64:89–92.
30.
NistalMMartinez-GarciaFRegaderaJCoboPPaniaguaR. Macroorchidism: Light and electron microscopic study of four cases. Hum Pathol1992;23:1011–1018.
31.
SomuncuSCakmakMCaglayanFAkmanHUlusoySKayaM. Idiopathic benign bilateral testicular enlargement in a pubertal boy: A case report and review of literature. J Pediatr Surg2005;40:e23–25.
32.
VelagaMRWrightCCroftonPMAllenLJenningsCECheethamTD. Macroorchidism in two unrelated prepubertal boys with a normal FSH receptor. Horm Res2005;64:3–8.
33.
AdebMDargeKSnyderH. Idiopathic macroorchidism with testicular lobulation in an adolescent. J Pediatr Urol2012;8:e10–12.
34.
Van EschH. The Fragile X premutation: New insights and clinical consequences. Eur J Med Genet2006;49:1–8.
35.
MartinJPBellJ. A Pedigree of mental defect showing sex-linkage. J Neurol Psychiatry1943;6:154–157.
36.
LubsHA. A marker X chromosome. Am J Hum Genet1969;21:231–244.
37.
HechtFLovrienEW. Genetic diagnosis in the newborn. A part of preventive medicine. Pediatr Clin North Am1970;17:1039–1053.
38.
CantuJMScagliaHEGonzalez-DiddiM. Inherited congenital normofunctional testicular hyperplasia and mental deficiency. A corroborative study. Hum Genet1978;41:331–339.
39.
HechtJTMooreCMScottCIJr. A recognizable syndrome of sex-linked mental retardation, large testes, and marker X chromosome. South Med J1981;74:1493–1496.
40.
Howard-PeeblesPNStoddardGR. Familial X-linked mental retardation with a marker X chromosome and its relationship to macroorchidism. Clin Genet1980;17:125–128.
41.
NielsenKBTommerupNDyggveHVSchouC. Macroorchidism and fragile X in mentally retarded males. Clinical, cytogenetic, and some hormonal investigations in mentally retarded males, including two with the fragile site at Xq28, fra(X)(q28). Hum Genet1982;61:113–117.
SutherlandGRAshforthPL. X-linked mental retardation with macroorchidism and the fragile site at Xq 27 or 28. Hum Genet1979;48:117–120.
44.
TurnerGDanielAFrostM. X-linked mental retardation, macroorchidism, and the Xq27 fragile site. J Pediatr1980;96:837–841.
45.
TurnerGEastmanCCaseyJMcLeayAProcopisPTurnerB. X-linked mental retardation associated with macroorchidism. J Med Genet1975;12:367–371.
46.
VoelckelMAPhilipNPiquetC. Study of a family with a fragile site of the X chromosome at Xq27-28 without mental retardation. Hum Genet1989;81:353–357.
47.
VerkerkAJPierettiMSutcliffeJS. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell1991;65:905–914.
48.
KremerEJPritchardMLynchM. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science1991;252(5013):1711–1714.
49.
OberleIRousseauFHeitzD. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science1991;252(5009):1097–1102.
50.
YuSPritchardMKremerE. Fragile X genotype characterized by an unstable region of DNA. Science1991;252(5009):1179–1181.
51.
JacquemontSHagermanRJLeeheyM. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am J Hum Genet2003;72:869–878.
52.
HoeftFCarterJCLightbodyAAHazlettH CodyPivenJReissAL. Region-specific alterations in brain development in one- to three-year-old boys with fragile X syndrome. Proc Natl Acad Sci U S A2010;107:9335–9339.
53.
KruegerDDBearMF. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med2011;62:411–429.
54.
ZalfaFAchselTBagniC. mRNPs, polysomes or granules: FMRP in neuronal protein synthesis. Curr Opin Neurobiol2006;16:265–269.
55.
WebbTPBundeySEThakeAIToddJ. Population incidence and segregation ratios in the Martin-Bell syndrome. Am J Med Genet1986;23:573–580.
56.
SaulRAFriezMEavesK. Fragile X syndrome detection in newborns-pilot study. Genet Med2008;10:714–719.
57.
HesslDRiveraSMReissAL. The neuroanatomy and neuroendocrinology of fragile X syndrome. Ment Retard Dev Disabil Res Rev2004;10:17–24.
58.
GarberKBVisootsakJWarrenST. Fragile X syndrome. Eur J Hum Genet2008;16:666–672.
59.
ZhangMWangQHuangY. Fragile X mental retardation protein FMRP and the RNA export factor NXF2 associate with and destabilize Nxf1 mRNA in neuronal cells. Proc Natl Acad Sci USA2007;104:10057–10062.
60.
ReissALAbramsMTGreenlawRFreundLDencklaMB. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med1995;1:159–167.
61.
GrecoCMBermanRFMartinRM. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain2006;129(Pt 1):243–255.
62.
HunsakerMRGrecoCMTassoneF. Rare intranuclear inclusions in the brains of 3 older adult males with fragile X syndrome: Implications for the spectrum of fragile X-associated disorders. J Neuropathol Exp Neurol2011;70:462–469.
63.
GrecoCMNavarroCSHunsakerMR. Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Molecular Autism2011;2:2.
64.
RudelliRDJenkinsECWisniewskiKMoretzRByrneJBrownWT. Testicular size in fetal fragile X syndrome. Lancet1983;1(8335):1221–1222.
65.
CarmiRMeryashDLWoodJGeraldPS. Fragile-X syndrome ascertained by the presence of macroorchidism in a 5-month-old infant. Pediatrics1984;74:883–886.
66.
JohannissonRRehderHWendtVSchwingerE. Spermatogenesis in two patients with the fragile X syndrome. I. Histology: Light and electron microscopy. Hum Genet1987;76:141–147.
67.
JohannissonRFroster-IskeniusUSaadallahNHultenMA. Spermatogenesis in two patients with the fragile X syndrome. II. First meiosis: Light and electron microscopy. Hum Genet1988;79:231–234.
68.
GrecoCMSoontrapornchaiKWirojananJGouldJEHagermanPJHagermanRJ. Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome. J Urol2007;177:1434–1437.
69.
HaddadLAMingroni-NettoRCVianna-MorganteAMPenaSD. A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males. Hum Genet1996;97:808–812.
70.
OostraBAWillemsenR. Diagnostic tests for fragile X syndrome. Expert Rev Mol Diagn.2001;1:226–32.
71.
TzengCCChoWCKuoPLChenRM. Pilot fragile X screening in normal population of Taiwan. Diagn Mol Pathol1999;8:152–156.
72.
RousseauFLabelleYBussieresJLindsayC. The fragile X mental retardation syndrome 20 years after the FMR1 gene discovery: An expanding universe of knowledge. Clin Biochem Rev2011;32:135–162.
73.
SofocleousCKolialexiAMavrouA. Molecular diagnosis of Fragile X syndrome. Expert Rev Mol Diagn2009;9:23–30.
74.
KaufmannWEReissAL. Molecular and cellular genetics of fragile X syndrome. Am J Med Genet1999;88:11–24.
75.
PopASGomez-MancillaBNeriGWillemsenRGaspariniF. Fragile X syndrome: A preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development. Psychopharmacology (Berl)2014;231:1217–1226.
76.
JohnsonJPNelsonRSchwartzCE. A family with mental retardation, variable macrocephaly and macroorchidism, and linkage to Xq12-q21. J Med Genet1998;35:1026–1030.
77.
FlynnBJMyersSMCeraPJMowadJJ. Testicular torsion in an adolescent with Fragile X Syndrome. Pediatrics2002;109:E16.
78.
PhelanMCStevensonRECollinsJLTrentHEIII. Fragile X syndrome and neoplasia. Am J Med Genet1988;30:77–82.
79.
HeseltineDWhiteMCKendall-TaylorPDe KretserDMKellyW. Testicular enlargement and elevated serum inhibin concentrations occur in patients with pituitary macroadenomas secreting follicle stimulating hormone. Clin Endocrinol (Oxf)1989;31:411–423.
80.
CorderoGLGraciaRNistalMLledoGPeraltaA. [Hypothyroidism and precocious testicular maturation. Report of a case and review of the literature]. Rev Clin Esp1973;128:83–88.
81.
LaronZKarpMDolbergL. Juvenile hypothyroidism with testicular enlargement. Acta Paediatr Scand1970;59:317–322.
82.
Van WykJJArnoldMB. Early recognition of cretinism. Pediatrics1960;26:732–734.
83.
HemadyZSSiler-KhodrTMNajjarS. Precocious puberty in juvenile hypothyroidism. J Pediatr1978;92:55–59.
84.
ShuperALaronZ. [Precocious puberty in a boy with inadequately treated primary hypothyroidism]. Harefuah1978;95:335–337.
85.
JanniniEAUlisseSD'ArmientoM. Thyroid hormone and male gonadal function. Endocr Rev1995;16:443–459.
86.
PringlePJStanhopeRHindmarshPBrookCG. Abnormal pubertal development in primary hypothyroidism. Clin Endocrinol (Oxf)1988;28:479–486.
87.
BarnesNDHaylesABRyanRJ. Sexual maturation in juvenile hypothyroidism. Mayo Clin Proc.1973;48:849–56.
88.
Castro-MaganaMAnguloMCanasASharpAFuentesB. Hypothalamic-pituitary gonadal axis in boys with primary hypothyroidism and macroorchidism. J Pediatr1988;112:397–402.
89.
MaranRR. Thyroid hormones: Their role in testicular steroidogenesis. Arch Androl2003;49:375–388.
90.
De La BalzeFAArrillagaFManciniREJanchesMDavidsonOWGurtmanAI. Male hypogonadism in hypothyroidism: A study of six cases. J Clin Endocrinol Metab1962;22:212–222.
91.
HoffmanWHKovacsKTGalaRR. Macroorchidism and testicular fibrosis associated with autoimmune thyroiditis. J Endocrinol Invest1991;14:609–616.
92.
Mendis-HandagamaSMAriyaratneHB Siril. Leydig cells, thyroid hormones and steroidogenesis. Indian J Exp Biol2005;43:939–962.
93.
EsenIDemirelF. Hypothyroidism-associated testicular enlargement: Is it a form of precocious puberty or not? A case report. Turk J Pediatr2011;53:210–212.
HopwoodNJLockhartLHBryanGT. Acquired hypothyroidism with muscular hypertrophy and precocious testicular enlargement. J Pediatr1974;85:233–236.
96.
BruderJMSamuelsMHBremnerWJRidgwayECWiermanME. Hypothyroidism-induced macroorchidism: Use of a gonadotropin-releasing hormone agonist to understand its mechanism and augment adult stature. J Clin Endocrinol Metab1995;80:11–16.
97.
WiermanMEBruderJMKepaJK. Regulation of gonadotropin-releasing hormone (GnRH) gene expression in hypothalamic neuronal cells. Cell Mol Neurobiol1995;15:79–88.
98.
AnastiJNFlackMRFroehlichJNelsonLMNisulaBC. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab1995;80:276–279.
99.
SuarezEAd'AlvaCBCampbellA. Absence of mutation in the follicle-stimulating hormone receptor gene in severe primary hypothyroidism associated with gonadal hyperstimulation. J Pediatr Endocrinol Metab2007;20:923–931.
100.
De FrancaLRHessRACookePSRussellLD. Neonatal hypothyroidism causes delayed Sertoli cell maturation in rats treated with propylthiouracil: Evidence that the Sertoli cell controls testis growth. Anat Rec1995;242:57–69.
101.
PalmeroSPratiMBollaFFugassaE. Tri-iodothyronine directly affects rat Sertoli cell proliferation and differentiation. J Endocrinol1995;145:355–362.
102.
SimorangkirDRde KretserDMWrefordNG. Increased numbers of Sertoli and germ cells in adult rat testes induced by synergistic action of transient neonatal hypothyroidism and neonatal hemicastration. J Reprod Fertil1995;104:207–213.
103.
van HaasterLHde JongFHDocterRde RooijDG. High neonatal triiodothyronine levels reduce the period of Sertoli cell proliferation and accelerate tubular lumen formation in the rat testis, and increase serum inhibin levels. Endocrinology1993;133:755–760.
104.
SunYBakBSchoenmakersN. Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nat Genet2012;44:1375–1381.
105.
DiamondFBJr. Pituitary adenomas in childhood: Development and diagnosis. Fetal Pediatr Pathol2006;25:339–356.
106.
HansonPLAylwinSJMonsonJPBurrinJM. FSH secretion predominates in vivo and in vitro in patients with non-functioning pituitary adenomas. Eur J Endocrinol2005;152:363–370.
107.
DahlqvistPKoskinenLOBrannstromTHaggE. Testicular enlargement in a patient with a FSH-secreting pituitary adenoma. Endocrine2010;37:289–293.
108.
SizonenkoPC. Normal sexual maturation. Pediatrician1987;14:191–201.
109.
EugsterEA. Peripheral precocious puberty: Causes and current management. Horm Res2009;71(Suppl 1):64–67.
110.
LeePA. Central precocious puberty. An overview of diagnosis, treatment, and outcome. Endocrinol Metab Clin North Am1999;28:901–918, xi.
111.
ColacoP. Precocious puberty. Indian J Pediatr1997;64:165–175.
112.
PartschCJHegerSSippellWG. Management and outcome of central precocious puberty. Clin Endocrinol (Oxf)2002;56:129–148.
113.
CacciariEZucchiniSCarlaG. Endocrine function and morphological findings in patients with disorders of the hypothalamo-pituitary area: A study with magnetic resonance. Arch Dis Child1990;65:1199–202.
114.
FahmyJLKaminskyCKKaufmanFNelsonMDJrParisiMT. The radiological approach to precocious puberty. Br J Radiol2000;73(869):560–567.
115.
FaizahMZuhanisARahmahR. Precocious puberty in children: A review of imaging findings. Biomed Imaging Interv J2012;8:e6.
116.
BierichJR. Sexual precocity. Clin Endocrinol Metab1975;4:107–142.
AdanLBussieresLDinandVZerahMPierre-KahnABraunerR. Growth, puberty and hypothalamic-pituitary function in children with suprasellar arachnoid cyst. Eur J Pediatr2000;159:348–355.
119.
BraunerRPierre-KahnANemedy-SandorERappaportRHirschJF. [Precocious puberty caused by a suprasellar arachnoid cyst. Analysis of 6 cases]. Arch Fr Pediatr1987;44:489–493.
120.
MohnASchoofEFahlbuschRWenzelDDorrHG. The endocrine spectrum of arachnoid cysts in childhood. Pediatr Neurosurg1999;31:316–321.
121.
KumarKVVermaAModiKDRayuduBR. Precocious puberty and pineal cyst—an uncommon association. Indian Pediatr2010;47:193–194.
122.
FilhoPR BenitesSakamotoDMachucaTNSerapiaoMJDitzelLTorresLF Bleggi. Granular cell tumor of the neurohypophysis: Report of a case with unusual age presentation. Virchows Arch2005;447:649–652.
123.
Bovier-LapierreMSempeMDavidM. [Etiological, clinical and biological aspects of precocious puberty of central origin]. Pediatrie1972;27:587–609.
124.
ShaulPWTowbinRBChernausekSD. Precocious puberty following severe head trauma. Am J Dis Child1985;139:467–469.
125.
SockaloskyJJKrielRLKrachLESheehanM. Precocious puberty after traumatic brain injury. J Pediatr1987;110:373–377.
126.
MorelloAPorcaroSLimaJImpallariaP. Endocrine disorder as the only sign of chronic “non-hypertensive” hydrocephalus. J Neurosurg Sci2002;46:81–84.
127.
VieiraTCChinenRNRibeiroMRNogueiraRGAbuchamJ. Central precocious puberty associated with pituitary duplication and midline defects. J Pediatr Endocrinol Metab2007;20: 1141–1144.
128.
VirdisRSigoriniMLaioloA. Neurofibromatosis type 1 and precocious puberty. J Pediatr Endocrinol Metab2000;13(Suppl 1):841–844.
129.
BraunerRCzernichowPRappaportR. Precocious puberty after hypothalamic and pituitary irradiation in young children. N Engl J Med1984;311:920.
130.
LeiperADStanhopeRKitchingPChessellsJM. Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child1987;62:1107–1112.
131.
BraunerRRappaportR. Precocious puberty secondary to cranial irradiation for tumors distant from the hypothalamo-pituitary area. Horm Res1985;22:78–82.
132.
NabhanZMMieszczakJEugsterEA. Combined central precocious puberty and primary gonadal failure after treatment of childhood malignancy in two boys: A diagnostic and therapeutic conundrum. J Pediatr2010;157:507–509.
133.
De SanctisVCorriasARizzoV. Etiology of central precocious puberty in males: The results of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab2000;13(Suppl 1):687–693.
134.
FeuillanPPJonesJVBarnesKMOerter-KleinKCutlerGBJr. Boys with precocious puberty due to hypothalamic hamartoma: Reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy. J Clin Endocrinol Metab2000;85:4036–4038.
135.
ShahPPatkarDPatankarTShahJSrinivasaPKrishnanA. MR imaging features in hypothalamic hamartoma: A report of three cases and review of literature. J Postgrad Med1999;45:84–86.
136.
JudgeDMKulinHEPageRSantenRTrapukdiS. Hypothalamic hamartoma: A source of luteinizing-hormone-releasing factor in precocious puberty. N Engl J Med1977;296:7–10.
137.
JungHCarmelPSchwartzMS. Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J Clin Endocrinol Metab1999;84:4695–4701.
138.
BanerjeeIClaytonP. The genetic basis for the timing of human puberty. J Neuroendocrinol2007;19:831–838.
139.
SeminaraSBMessagerSChatzidakiEE. The GPR54 gene as a regulator of puberty. N Engl J Med2003;349:1614–1627.
140.
StephenMDZagePEWaguespackSG. Gonadotropin-dependent precocious puberty: Neoplastic causes and endocrine considerations. Int J Pediatr Endocrinol2011;2011:184502.
141.
TandonNChopraRGhoshalSSinghPSharmaBS. Mixed germ cell tumour of the pineal region: A case report. Neurol India1999;47:321–323.
142.
Soriano-GuillenLCorripioRLabartaJI. Central precocious puberty in children living in Spain: Incidence, prevalence, and influence of adoption and immigration. J Clin Endocrinol Metab2010;95:4305–4313.
143.
DengFTaoFBLiuDY. Effects of growth environments and two environmental endocrine disruptors on children with idiopathic precocious puberty. Eur J Endocrinol2012;166:803–809.
144.
de VriesLKauschanskyAShohatMPhillipM. Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab2004;89:1794–1800.
145.
AbreuAPDauberAMacedoDB. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med2013;368:2467–2475.
146.
ParentASMatagneVWestphalMHegerSOjedaSJungH. Gene expression profiling of hypothalamic hamartomas: A search for genes associated with central precocious puberty. Horm Res2008;69:114–123.
147.
SilveiraLGNoelSDSilveira-NetoAP. Mutations of the KISS1 gene indisorders of puberty. J Clin Endocrinol Metab2010;95:2276–2280.
148.
TelesMGBiancoSDBritoVN. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med2008;358:709–715.
149.
VerkauskieneRPetraitieneIWiklandK Albertsson. Puberty in children born small for gestational age. Horm Res Paediatr2013;80:69–77.
150.
PigneurBTrivinCBraunerR. Idiopathic central precocious puberty in 28 boys. Med Sci Monit2008;14:CR10–CR14.
HayashidaYHiraiTKorogiY. Pineal cystic germinoma with syncytiotrophoblastic giant cells mimicking MR imaging findings of a pineal cyst. AJNR Am J Neuroradiol2004;25:1538–1540.
153.
KuoHCSheenJMWuKSWeiHHHsiaoCC. Precocious puberty due to human chorionic gonadotropin-secreting pineal tumor. Chang Gung Med J2006;29:198–202.
154.
NogueiraKLibermanBPimentel-FilhoFR. hCG-secreting pineal teratoma causing precocious puberty: Report of two patients and review of the literature. J Pediatr Endocrinol Metab2002;15:1195–1201.
155.
ShenkerALaueLKosugiSMerendinoJJJrMinegishiTCutlerGBJr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature1993;365(6447):652–654.
156.
RosenthalSMGrumbachMMKaplanSL. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): Effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab1983;57:571–579.
157.
SchedewieHKReiterEOBeitinsIZ. Testicular leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab1981;52:271–278.
158.
WiermanMEBeardsworthDEMansfieldMJ. Puberty without gonadotropins. A unique mechanism of sexual development. N Engl J Med1985;312:65–72.
159.
LatronicoACAbellANArnholdIJ. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab1998;83:2435–2440.
160.
LatronicoACAnastiJArnholdIJ. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab1995;80:2490–2494.
161.
LatronicoACShinozakiHGuerraGJr. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: A novel constitutively activating mutation in the first transmembrane helix. J Clin Endocrinol Metab2000;85:4799–4805.
162.
LaueLChanWYHsuehAJ. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA1995;92:1906–1910.
163.
NagasakiKKatsumataNOgawaYKikuchiTUchiyamaM. Novel C617Y mutation in the 7th transmembrane segment of luteinizing hormone/choriogonadotropin receptor in a Japanese boy with peripheral precocious puberty. Endocr J2010;57:1055–1060.
164.
Rousseau-MerckMFMisrahiMAtgerMLoosfeltHMilgromEBergerR. Localization of the human luteinizing hormone/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21. Cytogenet Cell Genet1990;54:77–79.
165.
Soriano-GuillenLMitchellVCarelJCBarbetPRogerMLahlouN. Activating mutations in the luteinizing hormone receptor gene: A human model of non-follicle-stimulating hormone-dependent inhibin production and germ cell maturation. J Clin Endocrinol Metab2006;91:3041–3047.
166.
GondosBEgliCARosenthalSMGrumbachMM. Testicular changes in gonadotropin-independent familial male sexual precocity. Familial testotoxicosis. Arch Pathol Lab Med1985;109:990–995.
167.
CantoPSoderlundDRamonGNishimuraEMendezJP. Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors. Am J Med Genet2002;108:148–152.
168.
PiolatCDyonJFChavanisNJacquierCDurandCPasquierD. [Testicular Leydig cell hyperplasia in children]. Prog Urol2003;13:110–114.
169.
HollandFJKirschSESelbyR. Gonadotropin-independent precocious puberty (“testotoxicosis”): Influence of maturational status on response to ketoconazole. J Clin Endocrinol Metab1987;64:328–333.
170.
AlmeidaMQBritoVNLinsTS. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clin Endocrinol (Oxf)2008;69:93–98.
171.
Eyssette-GuerreauSPintoGSultanALe MerrerMSultanCPolakM. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty. J Pediatr Endocrinol Metab2008;21:995–1002.
172.
LenzAMShulmanDEugsterEA. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics2010;126;e728–e733.
173.
NistalMPaniaguaRGonzalez-PeramatoPReyes-MugicaM. Perspectives in pediatric pathology, chapter 6: Male under-masculinization. Pediatr Dev Pathol2015;18:279–296.
174.
GraciaRNistalMGallegoME. [Leydig cell tumor with pseudoprecocious puberty (author's transl)]. An Esp Pediatr1980;13:593–598.
175.
d'AlvaCBBritoVNPalharesHM. A single somatic activating Asp578His mutation of the luteinizing hormone receptor causes Leydig cell tumour in boys with gonadotropin-independent precocious puberty. Clin Endocrinol (Oxf)2006;65:408–410.
176.
KimIYoungRHScullyRE. Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol1985;9:177–192.
177.
PolepalleSKShabaikAAlagiriM. Leydig cell tumor in a child with spermatocyte maturation and no pseudoprecocious puberty. Urology2003;62:551.
178.
DominguezFJ AlonsoAcostaVA Osorio. [Leydig cell tumor presenting as precocious pseudopuberty in a 4-year-old boy]. Arch Esp Urol2004;57:426–428.
LeungACKoganSJ. Focal lobular spermatogenesis and pubertal acceleration associated with ipsilateral Leydig cell hyperplasia. Urology2000;56:508–509.
181.
TaziMFMellasSEl FassiMJFarihMH. Leydig cell hyperplasia revealed by gynecomastia. Rev Urol.2008;10:164–167.
182.
BerenszteinEBelgoroskyAde DavilaMTRivarolaMA. Testicular steroid biosynthesis in a boy with a large cell calcifying Sertoli cell tumor producing prepubertal gynecomastia. Steroids1995;60:220–225.
183.
DiamondFB.JrRootAWHooverDLMonteforteH. Hetero-and isosexual pseudoprecocity associated with testicular sex-cord tumors in an 8 year-old male. J Pediatr Endocrinol Metab1996; 9:407–414.
184.
CoenPKulinHBallantineT. An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. N Engl J Med1991;324:317–322.
185.
RosPNistalMAlonsoMde MoraJ CalvoYturriagaRBarrioR. Sertoli cell tumour in a boy with Peutz-Jeghers syndrome. Histopathology1999;34:84–86.
186.
CarneyJA. Carney complex: The complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Semin Dermatol1995;14:90–98.
187.
BonfigWBittmannIBechtoldS. Virilising adrenocortical tumours in children. Eur J Pediatr2003;162:623–628.
188.
DragoJRSheikholislamBOlsteinJSPalmerJMTeslukHLinkD. Virilizing adrenal cortical carcinoma with hypertrophy of spermatic tubules in childhood. Urology1979;14:70–75.
189.
CunnahDPerryLDacieJA. Bilateral testicular tumours in congenital adrenal hyperplasia: A continuing diagnostic and therapeutic dilemma. Clin Endocrinol (Oxf)1989;30:141–147.
190.
Al-JumailyUSammourIAl-MuhaisenFAjlouniFSultanI. Precocious puberty in an infant with hepatoblastoma: A case report. J Med Case Rep2011;5:422.
191.
BodeHHSchimanaWSwaiBBodeU. Sexual precocity associated with an abdominal tumor in an African boy. J Pediatr Endocrinol Metab2008;21:275–277.
192.
ErenEDemirkayaMCakirEDSevinirBSaglamHTarimO. A rare cause of precocious puberty: Hepatoblastoma. J Clin Res Pediatr Endocrinol2009;1:281–283.
193.
BowdenSAGermakJA. Klinefelter syndrome presenting with precocious puberty due to a human chorionic gonadotropin (hCG)-producing mediastinal germinoma. J Pediatr Endocrinol Metab2006;19:1371.
194.
GoswamiSChakrabortyPPBhattacharjeeR. Precocious puberty: A blessing in disguise!Indian J Endocrinol Metab2013;17(Suppl 1):S111–S113.
195.
MarshallGAMcMahonSKNichollsWPretoriusCJUngererJP. Gonadotrophin-independent precocious puberty in an eight-year-old boy due to ectopic human chorionic gonadotrophin from the central nervous system. Ann Clin Biochem2010;47(Pt 3):271–274.
196.
NairMKusumakumaryPNinanA. Precocious puberty as initial presentation in mediastinal tumour. Indian Pediatr2013;50:424–426.
197.
NascimentoDJLeaesCGPereira-LimaJFOliveiraMC. Precocious puberty due to human chorionic gonadotropin secreting germinoma. J Pediatr Neurosci2012;7:202–204.
198.
WendtSShelsoJWrightKFurmanW. Neoplastic causes of abnormal puberty. Pediatr Blood Cancer2014;61:664–671.
NebertDWNelsonDRAdesnikM. The P450 superfamily: Updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA1989;8:1–13.
201.
ChenSABesmanMJSparkesRS. Human aromatase: Cdna cloning, Southern blot analysis, and assignment of the gene to chromosome 15. DNA1988;7:27–38.
202.
LodishMBGartnerLAAlbiniP. Intrauterine growth retardation associated with precocious puberty and sertoli cell hyperplasia. Horm Metab Res2010;42:682–688.
203.
StratakisCAVotteroABrodieA. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab1998;83:1348–1357.
204.
TiulpakovAKalintchenkoNSemitchevaT. A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome. J Clin Endocrinol Metab2005;90:4184–4190.
205.
ShozuMSebastianSTakayamaK. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med2003;348:1855–1865.
206.
ShozuMAkasofuKHaradaTKubotaY. A new cause of female pseudohermaphroditism: Placental aromatase deficiency. J Clin Endocrinol Metab1991;72:560–566.
207.
DeladoeyJFluckCBexMYoshimuraNHaradaNMullisPE. Aromatase deficiency caused by a novel P450arom gene mutation: Impact of absent estrogen production on serum gonadotropin concentration in a boy. J Clin Endocrinol Metab1999;84:4050–4054.
208.
LanfrancoFZirilliLBaldiM. A novel mutation in the human aromatase gene: Insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone2008;43:628–635.
209.
van der EerdenBCKarperienMWitJM. The estrogen receptor in the growth plate: Implications for pubertal growth. J Pediatr Endocrinol Metab2001;14(Suppl 6):1527–1533.
210.
MaffeiLMurataYRochiraV. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: Effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab2004;89:61–70.
211.
ZirilliLRochiraVDiazziCCaffagniGCaraniC. Human models of aromatase deficiency. J Steroid Biochem Mol Biol2008;109:212–218.
212.
MaffeiLRochiraVZirilliL. A novel compound heterozygous mutation of the aromatase gene in an adult man: Reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin Endocrinol (Oxf)2007;67:218–224.
213.
CaraniCQinKSimoniM. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med1997;337:91–95.
214.
MorishimaAGrumbachMMSimpsonERFisherCQinK. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab1995;80:3689–3698.
215.
GrumbachMMAuchusRJ. Estrogen: Consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab1999;84:4677–4694.
216.
SmithEPBoydJFrankGR. Estrogen resistance caused by a mutation in the estrogen–receptor gene in a man. N Engl J Med1994;331:1056–1061.
217.
BilezikianJPMorishimaABellJGrumbachMM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med1998;339:599–603.
218.
EblingFJBrooksANCroninASFordHKerrJB. Estrogenic induction of spermatogenesis in the hypogonadal mouse. Endocrinology.2000;141:2861–2869.
219.
Faustini-FustiniMRochiraVCaraniC. Oestrogen deficiency in men: Where are we today?Eur J Endocrinol1999;140:111–129.
220.
DomeniceSLatronicoACBritoVNArnholdIJKokFMendoncaBB. Adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene. J Clin Endocrinol Metab2001;86:4068–4071.
221.
LandauZHanukogluASackJ. Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations. Clin Endocrinol (Oxf)2010;72:448–454.
222.
YesteDGonzalez-NinoCde NanclaresG Perez. ACTH-dependent precocious pseudopuberty in an infant with DAX1 gene mutation. Eur J Pediatr2009;168:65–69.
223.
McCuneDJ. Osteitis fibrosa cystica: The case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child1936;52:743–744.
224.
AlbrightFButlerAMHamptonMOSmithP. Syndrome characterized by osteitis fibrosa disseminata areas of pigmentation and endocrine dysfunction, with precocious puberty in females: Report of five cases. N Engl J Med1937;216:727–746.
225.
ArrigoTPirazzoliPDe SanctisL. McCune-Albright syndrome in a boy may present with a monolateral macroorchidism as an early and isolated clinical manifestation. Horm Res2006;65:114–119.
226.
SiadatiSShafighE. McCune-Albright syndrome: A case report. Arch Iran Med2010;13:245–247.
227.
WeinsteinLSShenkerAGejmanPVMerinoMJFriedmanESpiegelAM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med1991;325:1688–1695.
228.
de SanctisLDelmastroLRussoMCMatarazzoPLalaRde SanctisC. Genetics of McCune-Albright syndrome. J Pediatr Endocrinol Metab2006;19(Suppl 2):577–582.
229.
ZhouJSunLHCuiB. Genetic diagnosis of multiple affected tissues in a patient with McCune-Albright syndrome. Endocrine2007;31:212–217.
230.
LatronicoACSegaloffDL. Naturally occurring mutations of the luteinizing-hormone receptor: Lessons learned about reproductive physiology and G protein-coupled receptors. Am J Hum Genet1999;65:949–958.
231.
GiovannelliGBernasconiSBanchiniG. McCune-Albright syndrome in a male child: A clinical and endocrinologic enigma. J Pediatr1978;92:220–226.
232.
ChakrabartiSMarshallI. Another unusual presentation of McCune Albright syndrome with fibrous dysplasia, unilateral testicular enlargement, and testicular microlithiasis. J Pediatr Endocrinol Metab2010;23:513–515.
233.
WasniewskaMMatarazzoPWeberG. Clinical presentation of McCune-Albright syndrome in males. J Pediatr Endocrinol Metab2006;19(Suppl 2):619–622.
234.
CoutantRLumbrosoSReyR. Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)alpha gene mutation: An unusual expression of McCune-Albright syndrome in a prepubertal boy. J Clin Endocrinol Metab2001;86:1778–1781.
235.
ReyRAVenaraMCoutantR. Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macroorchidism without sexual precocity in McCune-Albright syndrome. Hum Mol Genet2006;15:3538–3543.
236.
De LucaFMitchellVWasniewskaM. Regulation of spermatogenesis in McCune-Albright syndrome: Lessons from a 15-year follow-up. Eur J Endocrinol2008;158:921–927.
237.
PapadopoulouMDoulaSKitsiosKKaltsasTKostaK. A boy with McCune-Albright syndrome associated with GH secreting pituitary microadenoma. Clinical findings and response to treatment. Hormones (Athens)2006;5:205–209.
238.
AdhvaryuKShanbagPVaidyaM. Tuberous sclerosis with hypothyroidism and precocious puberty. Indian J Pediatr2004;71:273–275.